Primary Diffuse Large B-Cell Lymphoma of the Descending Colon

Am J Med Sci. 2019 Aug;358(2):164-167. doi: 10.1016/j.amjms.2019.05.004. Epub 2019 May 23.

Abstract

Primary non-Hodgkin lymphoma of the gastrointestinal tract is rare with an incidence of 10-15% of all non-Hodgkin lymphoma cases and 1-4% of all gastrointestinal tumors. The most common sites of involvement include the stomach, small intestines, colon and rectum. Primary colorectal lymphoma is extremely rare representing only 0.2-0.6% of all colorectal malignancies. The presentation is usually non-specific leading to delay in diagnosis. Imaging is used to locate the tumor and its extension. Colonoscopy usually shows a fungating mass, infiltrative or ulcerative lesion. Diffuse large B-cell lymphoma is the most common histological subtype. Management of diffuse large B-cell lymphoma usually involves chemotherapy, radiation, surgery or a combination approach.

Keywords: Chemotherapy; Colonoscopy; Colorectal Neoplasms; Diffuse; Large B-cell; Lymphoma; Ulcer.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Colon, Descending / pathology*
  • Colon, Descending / surgery
  • Colonic Neoplasms / drug therapy
  • Colonic Neoplasms / pathology*
  • Colonic Neoplasms / surgery
  • Colonoscopy
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Lymphoma, Large B-Cell, Diffuse / pathology*
  • Lymphoma, Large B-Cell, Diffuse / surgery
  • Male
  • Middle Aged
  • Treatment Outcome